KLU156: Clinical Trials

1 trial of KLU156, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow KLU156: new trials by email Literature Review of KLU156 trials Research Report on KLU156

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
KLU156, Coartem - Uncomplicated Plasmodium Falciparum Malaria
Phase 3CompletedNovartis Pharmaceuticals17202024-03-072026-11-04

Conditions studied

Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Burkina Faso (1)  ·  Côte d’Ivoire (1)  ·  Democratic Republic of the Congo (1)  ·  Gabon (1)  ·  Ghana (1)  ·  Kenya (1)  ·  Mali (1)  ·  Niger (1)  ·  Rwanda (1)  ·  Tanzania (1)  ·  Uganda (1)  ·  Zambia (1)